INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 414m ago
HOUSE PTR14m ago
SEC 13F14m ago
ROBINHOOD CHAIN13m ago
Corporate insider
BI

Barchas Isaac

DirectorCIK 0001808343

EDGAR filingsOpen in network
Disclosed transactions9
Buys / sells0 / 9
Max Insider Score23
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$264K
10.1K sh
Aug 10, 2026Aug 12, 2026
traded Aug 10, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Immunome Inc.Director · Dec 23, 2025
19
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL
$1.63M
62.3K sh
Aug 11, 2026
Aug 12, 2026
traded Aug 11, 2026
+1d
SEC FORM 4

Evidence

8
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$301K
11.0K sh
Aug 12, 2026Aug 12, 2026
traded Aug 12, 2026
+0dSEC FORM 4

Evidence

11
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$543K
20.8K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC FORM 4

Evidence

11
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$397K
15.2K sh
Aug 7, 2026Aug 10, 2026
traded Aug 7, 2026
+3dSEC FORM 4

Evidence

16
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$409K
16.9K sh
Jul 7, 2026Jul 7, 2026
traded Jul 7, 2026
+0dSEC FORM 4

Evidence

23
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$2.00M
83.1K sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC FORM 4

Evidence

18
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$8.08M
371.9K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC FORM 4

Evidence

11
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$251K
11.3K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC FORM 4

Evidence